相关实验视频

Updated: Jun 27, 2025

Production of Human CRISPR-Engineered CAR-T Cells

Production of Human CRISPR-Engineered CAR-T Cells

Published on: March 15, 2021

基于生物材料的CRISPR/Cas9传递系统用于瘤治疗

Mengmeng Li¹, Fenglei Chen², Qian Yang¹

¹Department of Otorhinolaryngology Head and Neck Surgery, the Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, China.

Biomaterials research

|May 2, 2024

概括

克里斯普尔/卡斯9基因编辑为癌症治疗提供了希望,但需要更好的交付. 生物材料在瘤学中显示出作为CRISPR/Cas9传递的高效和生物相容载体的潜力.

科学领域:

生物技术和生物医学工程生物技术和生物医学工程
分子生物学和遗传学
瘤学和癌症研究研究.

背景情况:

克里斯普尔/卡斯9基因编辑技术在治疗遗传疾病方面表现出高的特异性和效率,包括具有多个遗传修饰的癌症.
临床翻译CRISPR/Cas9面临重大障碍,主要是需要优化交付载体.
生物材料正在成为CRISPR/Cas9传递载体的领先候选者,因为它们具有可调节性质,生物相容性和有效性.

研究的目的:

审查CRISPR/Cas9系统及其在瘤学中的治疗潜力.
分析各种传递载体,比较物理,病毒和非病毒选项.
探索基于生物材料的载体在瘤治疗中的CRISPR/Cas9传递的特征和最近的进展.

主要方法:

关于CRISPR/Cas9技术及其在癌症治疗中的应用的综合文献综述.
对不同传递载体系统 (物理,病毒,非病毒) 的比较分析.
详细检查生物材料的特性及其作为CRISPR/Cas9载体的适用性.
对生物材料介导的CRISPR/Cas9传递对特定瘤类型的当前研究的综述.

主要成果:

生物材料为CRISPR/Cas9交付提供了一个有希望的解决方案,解决了在特异性,生物相容性和效率方面的关键挑战.
不同的生物材料类型具有独特的特征,适用于不同的CRISPR/Cas9输送策略在瘤学中.
最近的研究强调了基于生物材料的CRISPR/Cas9系统在临床前瘤模型中的成功应用.

结论:

基于生物材料的载体代表了CRISPR/Cas9在癌症治疗中的临床应用的重大进展.
需要进一步的研究来克服现有的局限性,并优化这些系统以广泛的临床使用.
开发有效的生物材料输送系统对未来的瘤治疗有很大的前景.

更多相关视频

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells

Published on: July 22, 2019

Designing, Packaging, and Delivery of High Titer CRISPR Retro and Lentiviruses via Stereotaxic Injection

Designing, Packaging, and Delivery of High Titer CRISPR Retro and Lentiviruses via Stereotaxic Injection

Published on: May 23, 2016

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...